The primary objectives of the Biomolecular Research Core of the Diabetes and Endocrinology Research Center (DERC) are to provide high quality, cost-effective, sophisticated analytical and synthetic services, instrumentation and consultation in the areas of protein, and DNA sciences. To achieve these goals the following specific services are offered: Protein Sciences - Amino acid analysis; Edman and mass spectrometric peptide sequencing and phosphopeptide sequencing; Mass spectrometric protein and peptide analysis and determination of post-translational protein modifications; CD spectropoladmetry; Dynamic light scattering; Large and small-scale peptide synthesis and anti-peptide antigen production. Proteomic analyses using 2D PAGE and orthogonai chromatography coupled with nanospray i/ms/ms.
DNA Sciences - Automated DNA sequencing, genotyping and satellite mapping; DNA chemical
manipulation. Affymetrix GeneChip and custom microarray gene profiling. Quantitative RT-PCR. High throughput oligonucleotide synthesis and "boutique" oligonucleotide synthesis. Expert consultation on the planning and implementation of research projects and individual experiments.
These services are provided using either core personnel or the use of core instrumentation by trained investigators and students. Particular emphasis in the core is directed at the development of technologies and protocols which are in demand by investigators in the DERC. Recent expansion in the core includes a 2D gel electrophoresis service for sample preparation for mass spectrometric sequencing of proteins (proteomics), new mass spectrometers for ultra-high sensitivity protein sequence analysis, high throughput capillary DNA sequencer, high throughput oligonucleotide synthesizer; and a quantitative RT-PCR instrument for gene chip target validation and real-time PCR.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
065391526
UEI
JJG6HU8PA4S5
Project Start Date
01-February-2005
Project End Date
31-January-2008
Budget Start Date
01-February-2005
Budget End Date
31-January-2006
Project Funding Information for 2005
Total Funding
$113,445
Direct Costs
$76,652
Indirect Costs
$36,793
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Diabetes and Digestive and Kidney Diseases
$113,445
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P30DK063609-03 9002
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30DK063609-03 9002
Patents
No Patents information available for 5P30DK063609-03 9002
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30DK063609-03 9002
Clinical Studies
No Clinical Studies information available for 5P30DK063609-03 9002
News and More
Related News Releases
No news release information available for 5P30DK063609-03 9002
History
No Historical information available for 5P30DK063609-03 9002
Similar Projects
No Similar Projects information available for 5P30DK063609-03 9002